Nitric oxide synthase inhibitors modulate nerve growth factor-mediated regulation of amyloid precursor protein expression in PC12 cells

Journal of Neurochemistry

Volumn 101, Issue 2, 2007, Pages 422-433

  Binnington, Janet C ^a   Kalisch, Bettina E ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Amyloid precursor protein; Nerve growth factor; Nitric oxide; PC12 cells; Signal transduction

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; AMYLOID PRECURSOR PROTEIN; BISINDOLYLMALEIMIDE; DACTINOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; N(G) NITROARGININE METHYL ESTER; NERVE GROWTH FACTOR; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE C; S METHYLPSEUDOTHIOUREA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ENZYME INHIBITORS; MITOGEN-ACTIVATED PROTEIN KINASE 1; NERVE GROWTH FACTOR; NEURONS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PC12 CELLS; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; PROTEIN SYNTHESIS INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 34047118121     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04378.x     Document Type: Article

References (51)

1. Ando M., Oishi M., Takeda S., Iijima K., Isohara T., Nairn A. C., Kirino Y., Greengard P. and Suzuki T. (1999) Role of phosphorylation of Alzheimer's amyloid precursor protein during neuronal differentiation. J. Neurosci. 19, 4421-4427.
2. Bach J. H., Chae H. S., Rah J. C. et al. (2001) C-terminal fragment of amyloid precursor protein induces astrocytosis. J. Neurochem. 78, 109-120.
3. Bapat S., Verkleij A. and Post J. A. (2001) Peroxynitrite activates mitogen-activated protein kinase (MAPK) via a MEK-independent pathway: a role for protein kinase C. FEBS Lett. 499, 21-26.
4. nnr5 cells expressing TrkA receptors undergo morphological but not cholinergic phenotypic differentiation in response to NGF. J. Neurochem. 80, 501-511.
5. Bradford M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem. 72, 248-254.
6. Chernak J. M. (1993) Structural features of the 5′ upstream regulatory region of the gene encoding rat amyloid precursor protein. Gene 133, 255-260.
7. Conant K., Ahmed U., Schwartz J. P. and Major E. O. (1998) INF-γ inhibits AP-1 binding activity in human brain-derived cells through a nitric oxide dependent mechanism. J. Immunol. 88, 39-44.
8. Cook S. J., Aziz N. and McMahon M. (1999) The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19, 330-341.
9. Cosgaya J. M., Latasa M. J. and Pascual A. (1996) Nerve growth factor and ras regulate beta-amyloid precursor protein gene expression in PC12 cells. J. Neurochem. 67, 98-104.
10. Da Cruz e Silva E. H. and Da Cruz e Silva O. A. (2003) Protein phosphorylation and APP metabolism. Neurochem. Res. 28, 1553-1561.
11. De Strooper B. and Annaert W. (2000) Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell. Sci. 113, 1857-1870.
12. Farías M., San Martín R., Puebla C., Pearson J. D., Casado J. F., Pastor-Anglada M., Casanello M. and Sobrevia L. (2006) Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes. J. Cell. Physiol. 208, 451-460.
13. Fukayama R., Chandrasekaran K. and Rapoport S. I. (1993) Nerve growth factor -induced neuronal differentiation is accompanied by differential induction and localization of the amyloid precursor protein (APP) in PC12-cells and variant PC12S-cells. Mol. Brain Res. 17, 17-22.
14. Ge Y. W. and Lahiri D. K. (2002) Regulation of promoter activity of the APP gene by cytokines and growth factors: implications in Alzheimer's disease. Ann. NY Acad. Sci. 973, 463-467.
15. Haby C., Lisovoski F., Aunis D. and Zwiller J. (1994) Stimulation of the cyclic GMP pathway by NO induces expression of the immediate early genes c-fos and junB in PC12 cells. J. Neurochem. 62, 496-501.
16. Higgins G. A., Oyler G. A., Neve R. L., Chen K. S. and Gage F. (1990) Altered levels of amyloid protein precursor transcripts in the basal forebrain of behaviourally impaired aged rats. Proc. Natl Acad. Sci. USA 87, 3032-3036.
17. Huang E. J. and Reichardt L. F. (2003) Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609-642.
18. Kalisch B. E., Bock N. A., Davis W. and Rylett R. J. (2002) Inhibitors of nitric oxide synthase attenuate nerve growth factor-mediated increases in choline acetyltransferase gene expression in PC12 cells. J. Neurochem. 81, 624-635.
19. Kalisch B. E., Demeris C. S. and Rylett R. J. (2003) Modulation of nerve growth factor-induced activation of MAP kinase in PC12 cells by inhibitors of nitric oxide synthase. J. Biol. Chem. 87, 1321-1332.
20. Kanterwicz B. I., Knapp L. T. and Klann E. (1998) Stimulation of p42 and p44 mitogen-activated protein kinases by reactive oxygen species and nitric oxide in hippocampus. J. Neurochem. 70, 1000-1016.
21. Lahiri D. K. and Ghosh C. (1999) Increased vulnerability of neuronal cell lines to sodium nitroprusside-mediated toxicity caused by the decreased level of nitric oxide metabolites. J. Mol. Neurosci. 13, 77-92.
22. Lahiri D. K., Ghosh C. and Ge Y. W. (2003) A proximal gene promoter region for the beta-amyloid precursor protein provides a link between development, apoptosis and Alzheimer's disease. Ann. NY Acad. Sci. 1010, 643-647.
23. Liang M. and Knox F. G. (1999) Nitric oxide activates PKCalpha and inhibits Na+-K+-ATPase in opossum kidney cells. Am. J. Physiol. 277, F859-F865.
24. Luo J., Wallace M. S., Hawver D. B., Kusiak J. W. and Wallace W. C. (2001) Characterization of the neurotrophic interaction between nerve growth factor and secreted α-amyloid precursor protein. J. Neurosci. Res. 63, 410-420.
25. Luth H. and Arendt T. (1997) Co-expression of APP with cNOS but not iNOS after cortical injury in rat. Neuroreport 8, 2321-2324.
26. Mei J. M., Hord N. G., Winterstein D. F., Donald S. P. and Phang J. M. (2000) Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells. FASEB J. 14, 1188-1201.
27. Mills J., Laurent Charest D., Lam F., Beyreuther K., Ida N., Pelech S. L. and Reiner P. B. (1997) Regulation of amyloid precursor protein catabolism involves mitogen-activated protein kinase signal transduction pathway. J. Neurosci. 17, 9415-9422.
28. Milward E. A., Papadopoulos R., Fuller S. J., Moir R. D., Small D., Beyreuther K. and Masters C. L. (1992) The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 9, 129-137.
29. Morris B. J. (1995) Stimulation of immediate early gene expression in striatal neurons by nitric oxide. J. Biol. Chem. 270, 24 740-24 744.
30. Neve R. L., Finch E. A. and Dawes L. R. (1988) Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron 1, 669-677.
31. Ohyagi Y. and Tabira T. (1993) Effects of growth factors and cytokines on expression of amyloid beta protein precursor messenger RNAs in culture neuronal cells. Mol. Brain. Res. 18, 127-132.
32. Peunova N. and Enikolopov G. (1995) Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 375, 68-73.
33. Pilz R. B., Suhasini M., Idriss S., Meinkoth J. L. and Boss G. R. (1995) Nitric oxide and cGMP analogs activate transcription from AP-1 responsive promoters in mammalian cells. FASEB J. 9, 552-558.
34. Rah J. C., Kim H. S., Kim S. S., Bach J. H., Kim Y. S., Park C. H., Seo J. H., Jeong S. J. and Suh Y. H. (2001) Effects of carboxy terminal fragment of Alzheimer's amyloid precursor protein and amyloid beta-peptide on the production of cytokines and nitric oxide in glial cells. FASEB J. 15, 1463-1465.
35. Rossner S., Ueberham U., Schliebs R., Perez-Polo J. R. and Bigl V. (1998a) p75 and TrkA receptor signaling independently regulate APP mRNA expression, isoform composition and protein secretion in PC-12 cells. J. Neurochem. 71, 757-764.
36. Rossner S., Ueberham U., Schliebs R., Perez-Polo J. R. and Bigl V. (1998b) The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Prog. Neurobiol. 56, 541-569.
37. Salbaum J. M., Weidemeann A., Masters C. L. and Beyreuther K. (1989) The promoter of Alzheimer's disease amyloid A4 precursor gene. Prog. Clin. Biol. Res. 17, 277-283.
38. Seiger A., Nordberg A., von Holst H. et al. (1993) Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav. Brain Res. 57, 255-261.
39. Selkoe D. J. (1994) Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17, 489-517.
40. Selkoe D. J. (2004) Alzheimer disease: mechanistic understanding predicts novel therapies. Ann. Intern. Med. 140, 627-638.
41. d. J. Biol. Chem. 275, 3645-3654.
42. Sheehy A. M., Phung Y. T., Reimer R. K. and Black S. (1997) Growth factor induction of nitric oxide synthases in rat pheochromocytoma cells. Mol. Brain Res. 52, 71-77.
43. Smith C. J., Wion D. and Brachet P. (1991) Nerve growth factor-induced neuronal differentiation is accompanied by differential splicing of beta-amyloid precursor protein messenger RNAs in the PC12 cell line. Mol. Brain Res. 10, 351-354.
44. Song W. and Lahiri D. K. (1998a) Molecular cloning of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein: structural characterization and a comparative study with other species. Gene 217, 151-164.
45. Song W. and Lahiri D. K. (1998b) Functional identification of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein. Gene 217, 165-176.
46. Southan G. J., Szabo C. and Thiermermann C. (1995) Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br. J. Pharmacol. 114, 510-516.
47. Tanaka S., Shiojiri S., Takahashi Y., Kitaguchi N., Ito H., Kameyama M., Kimura J., Nakamura S. and Ueda K. (1989) Tissue-specific expression of three types of beta-protein precursor mRNA: enhancement of protease inhibitor-harboring types in Alzheimer's disease brain. Biochem. Biophys. Res. Commun. 165, 1406-1414.
48. Tanzi R. E., McClatchey A. I., Lampert E. D., Villa-Komaroff L., Gusella J. F. and Neve R. L. (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331, 528-530.
49. Villa A., Latasa M. J. and Pascual A. (2001) Nerve growth factor modulates the expression and secretion of beta-amyloid precursor protein through different mechanisms in PC12 cells. J. Neurochem. 77, 1077-1084.
50. Yamada T., Araki E., Izumi R., Goto I., Sasaki H. and Sakaki Y. (1991) Expression of Alzheimer amyloid-beta protein precursor gene in neuronal cells. Gerontology 37, 24-30.
51. Yamazaki M., Chibak K. and Mohri T. (2005) Fundamental role of nitric oxide in neuritogenesis of PC12h cells. Br. J. Pharmacol. 146, 662-669.